Literature DB >> 10988013

Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study.

F B Smith1, F G Fowkes, A Rumley, A J Lee, G D Lowe, C M Hau.   

Abstract

AIMS: To evaluate the relationship between haemostatic and rheological factors and cardiovascular outcome in subjects with angina pectoris in the general population. METHODS AND
RESULTS: Two hundred and seven men and women aged 55-74 had evidence of angina at baseline. Sixty-seven (32.3%) had a fatal or non-fatal cardiovascular event during follow-up. Median levels of tissue plasminogen activator antigen and leucocyte elastase were higher in the event group compared with the no event group (10.0 ng. ml(-1)vs 7.2 ng. ml(-1);P</=0.001, and 40.3 ng. ml(-1)vs 31.0 ng. ml(-1);P</=0.01, respectively). Whole blood viscosity was also significantly higher in the event group than in the no event group (3.80 mPa.s vs 3.53 mPa.s;P</=0.05). After adjusting for age and sex, unit increases in both tissue plasminogen activator antigen and leucocyte elastase levels were significantly associated with an increased risk of a cardiovascular event. These associations remained after further adjusting for cardiovascular risk factors and baseline myocardial infarction. The relative risks were 2.07 (95% CI, 1.30-3.45;P</=0.01) for tissue plasminogen activator antigen and 1. 95 (95% CI, 1.12-3.50;P</=0.05) for leucocyte elastase.
CONCLUSION: Disturbed fibrinolysis and activation of leucocytes may be implicated in the development of thrombotic cardiovascular events in subjects with angina pectoris in the general population. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988013     DOI: 10.1053/euhj.2000.2127

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice.

Authors:  R E Young; M-B Voisin; S Wang; J Dangerfield; S Nourshargh
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Authors:  Binita Shah; Jeffrey S Berger; Nicole Allen; Yu Guo; Steven P Sedlis; Jinfeng Xu; Adriana Perez; Michael Attubato; James Slater; Frederick Feit
Journal:  Catheter Cardiovasc Interv       Date:  2016-01-16       Impact factor: 2.692

3.  The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial.

Authors:  Immi Kormi; Hatem Alfakry; Taina Tervahartiala; Pirkko J Pussinen; Juha Sinisalo; Timo Sorsa
Journal:  Inflamm Res       Date:  2013-12-31       Impact factor: 4.575

4.  Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.

Authors:  Guanmei Wen; Weiwei An; Jiangyong Chen; Eithne M Maguire; Qishan Chen; Feng Yang; Stuart W A Pearce; Maria Kyriakides; Li Zhang; Shu Ye; Sussan Nourshargh; Qingzhong Xiao
Journal:  J Am Heart Assoc       Date:  2018-02-08       Impact factor: 5.501

5.  Neutrophil elastase plays a non-redundant role in remodeling the venular basement membrane and neutrophil diapedesis post-ischemia/reperfusion injury.

Authors:  Mathieu-Benoit Voisin; Giovanna Leoni; Abigail Woodfin; Laure Loumagne; Nimesh Sa Patel; Rosanna Di Paola; Salvatore Cuzzocrea; Christoph Thiemermann; Mauro Perretti; Sussan Nourshargh
Journal:  J Pathol       Date:  2019-03-22       Impact factor: 7.996

6.  The role of neutrophil elastase in aortic valve calcification.

Authors:  Yan Liu; Peng Jiang; Liqin An; Mengying Zhu; Jin Li; Yue Wang; Qin Huang; Yi Xiang; Xiaorong Li; Qiong Shi; Yaguang Weng
Journal:  J Transl Med       Date:  2022-04-09       Impact factor: 5.531

7.  Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.

Authors:  Fadia Mayyas; Eman Bani Omar
Journal:  Heliyon       Date:  2022-06-30

8.  Acute coronary syndromes: from the laboratory markers to the coronary vessels.

Authors:  Palazzuoli Alberto; Iovine Francesca; Scali Chiara; Nuti Ranuccio
Journal:  Biomark Insights       Date:  2007-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.